• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Resources

Scientific articles

Home > Resources

Scientific articles

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2025

Results

No results found. Please try using different filter option(s).

Press releases
27 Nov 2025

International seminar explores the development of treatments for dengue for populations not covered by vaccines

News
26 Nov 2025

DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment

Dr Pauline Williams
Videos
24 Nov 2025

Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair

Scientific articles
20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers
Viewpoints
20 Nov 2025

Neglecting infectious diseases is a market failure

Financial Times
Videos
20 Nov 2025

Beni: Surviving Sleeping Sickness

Publications
17 Nov 2025

Open Science in a Closed World

News
17 Nov 2025

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations 

In the media
16 Nov 2025

Fra flue til flue har denne fjende hærget Afrika. Men nu er sejren mod sovesyge lige om hjørnet

Verdens Bedste Nyheder
Statements
13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

EFE logo
In the media
12 Nov 2025

Varios activistas climáticos invaden el área restringida de la COP30 durante una protesta

EFE
The British Medical Journal logo
In the media
11 Nov 2025

Policies to promote affordability and access across the life cycle of costly new drugs

The BMJ
Press releases
10 Nov 2025

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

New Vision logo
In the media
7 Nov 2025

Hope for millions as over sh180b invested to develop new drugs for dengue fever

New Vision
AFP logo
In the media
4 Nov 2025

Dengue : l’Europe investit 20 millions d’euros pour développer de nouveaux traitements

AFP
Press releases
4 Nov 2025

European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

loading
Loading...
Scientific articles
20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers
Scientific articles
7 Oct 2025

Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)

The Lancet Infectious Diseases
Scientific articles
30 Sep 2025

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

BMJ Open
Scientific articles
29 Sep 2025

Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala

Journal of the Brazilian Society of Tropical Medicine
Scientific articles
22 Sep 2025

Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans

Antimicrobial Agents and Chemotherapy
Scientific articles
18 Sep 2025

Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of eumycetoma

RSC Medicinal Chemistry
Scientific articles
8 Sep 2025

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials

The Lancet Microbe
Scientific articles
11 Aug 2025

Collaborative synthesis for neglected diseases through the Open Synthesis Network: structure–activity relationships of arylaminopyrazoles as Chagas disease treatments

ACS Infectious Diseases
Scientific articles
9 Jul 2025

Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas disease

Science Translational Medicine
Scientific articles
26 Jun 2025

Validated LC-MS/MS method for quantifying the antiparasitic nitroimidazole DNDI-0690 in preclinical target site PK/PD studies

Biomedical Chromatography
Scientific articles
25 Jun 2025

“Female Genital Schistosomiasis: Translational Challenges and Opportunities”: Outputs and actions from a consultative, collaborative and translational workshop

Parasitology
Scientific articles
28 May 2025

Pharmacokinetics and pharmacodynamics of fosravuconazole, itraconazole, and hydroxyitraconazole in Sudanese patients with eumycetoma

The Journal of Infectious Diseases
Scientific articles
26 May 2025

Traitement oral de la trypanosomiase humaine africaine : faisabilité dans les communautés du littoral Guinéen

Santé Publique
Scientific articles
15 May 2025

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study

Journal of Chromatography B
Scientific articles
13 May 2025

Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease

PLOS Neglected Tropical Diseases
Scientific articles
9 May 2025

Efficient constitution of a library of rotenoid analogs active against Trypanosoma cruzi from a digitalized plant extract collection

RSC Advances
1 2 … 41 ›

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license